IGVH MUTATION DETECTION, SCREENING
This assay is useful to provide an estimate of prognosis (aggressiveness of disease) of B-cell Chronic lymphocytic leukemia (B-CLL) and to help evaluate treatment options. B-CLL with mutated (>2% mutation) IgVH is typically less aggressive (more slowly progressive) than B-CLL with unmutated (<2%) IgVH.
Parameter(s) covered : 1
Report Frequency: Sample Mon by 9 am; Report Fri
Special Instruction: No special preparation required
Price : ₹ 8100.00
Parameters
- IgVH MUTATION DETECTION